The Enduring Legacy of Failed Revascularization Trials
- PMID: 34736564
- DOI: 10.1016/j.jacc.2021.08.059
The Enduring Legacy of Failed Revascularization Trials
Keywords: clinical trial; coronary artery disease; pressure wire.
Conflict of interest statement
Funding Support and Author Disclosures Dr Dauerman has served as a consultant for and received research grant support from Medtronic and Boston Scientific. Dr Montalescot has received institutional research funds or fees from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cell Prothera, CSL Behring, Europa, Idorsia, IRIS-Servier, Medtronic, MSD, Novartis, Pfizer, Quantum Genomics, and Sanofi. Dr Tijssen has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.J Am Coll Cardiol. 2021 Nov 9;78(19):1875-1885. doi: 10.1016/j.jacc.2021.08.061. J Am Coll Cardiol. 2021. PMID: 34736563 Clinical Trial.